Dendreon to Build $70 Million Plant Near Atlanta
The 160,000 square-foot facility could bring at least 300 jobs to Georgia.
mitchell h. gold
Provenge Extends Life of Prostate Cancer Patients, Study Finds
Researchers found that Dendreon’s immunotherapy drug Provenge prolonged the lives of advanced prostate cancer patients by an average of 4.1 months compared to a placebo.